We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Presidio Property Trust
SQFT
$3.01M
| $27K | ﹤0.01% |
2,160
-800
| -27% | -$21.5K |
|
|
STRR
2427
DELISTED
Star Equity Holdings
STRR
| $27K | ﹤0.01% |
5,380
-2,120
| -28% | -$10.8K |
|
|
KG
2428
Kestrel Group
KG
$68M
| $26K | ﹤0.01% |
612
-1,130
| -65% | -$48K |
|
2429
Protalix BioTherapeutics
PLX
$188M
| $26K | ﹤0.01% |
25,300
-48,371
| -66% | -$53.6K |
|
|
AMPE
2430
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $26K | ﹤0.01% |
1,441
+1,085
| +305% | +$38K |
|
2431
Laird Superfood
LSF
$46.8M
| $25K | ﹤0.01% |
13,500
-13,600
| -50% | -$30.1K |
|
|
GRTX
2432
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $25K | ﹤0.01% |
14,100
-36,800
| -72% | -$52K |
|
2433
Fortress Biotech
FBIO
$113M
| $24K | ﹤0.01% |
1,847
-86
| -4% | -$1.29K |
|
2434
Cytosorbents Corp
CTSO
$23.3M
| $23K | ﹤0.01% |
16,600
-10,900
| -40% | -$21.3K |
|
|
ZEPP
2435
Zepp Health
ZEPP
$68M
| $23K | ﹤0.01% |
4,267
-7,650
| -64% | -$55.3K |
|
|
SCTL
2436
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $23K | ﹤0.01% |
14,100
-6,400
| -31% | -$7.45K |
|
|
VISL
2437
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
| $22K | ﹤0.01% |
2,565
-55
| -2% | -$620 |
|
2438
Alset
AEI
$40.5M
| $21K | ﹤0.01% |
4,170
-135
| -3% | -$762 |
|
|
FRSX
2439
Foresight Autonomous Holdings
FRSX
$3.58M
| $21K | ﹤0.01% |
310
-184
| -37% | -$15.6K |
|
|
RTB
2440
RTB Digital
RTB
$256M
| $21K | ﹤0.01% |
+61
| New | +$22K |
|
|
FABC
2441
Fabric.AI Inc
FABC
$16.5M
| $20K | ﹤0.01% |
270
-302
| -53% | -$34.5K |
|
2442
NexGel
NXGL
$4.06M
| $20K | ﹤0.01% |
12,950
-900
| -6% | -$1.6K |
|
2443
Pyxis Oncology
PYXS
$184M
| $20K | ﹤0.01% |
+10,400
| New | +$27.2K |
|
2444
Plus Therapeutics
PSTV
$25.9M
| $19K | ﹤0.01% |
113
-19
| -14% | -$4.24K |
|
|
SOND
2445
DELISTED
Sonder
SOND
| $19K | ﹤0.01% |
575
-130
| -18% | -$4.32K |
|
|
CDTX
2446
DELISTED
Cidara Therapeutics
CDTX
| $18K | ﹤0.01% |
1,410
-525
| -27% | -$7.25K |
|
2447
Precision BioSciences
DTIL
$185M
| $18K | ﹤0.01% |
463
-890
| -66% | -$42.3K |
|
|
OCFT
2448
DELISTED
OneConnect Financial Technology
OCFT
| $17K | ﹤0.01% |
2,390
-970
| -29% | -$12.8K |
|
2449
Seanergy Maritime Holdings
SHIP
$348M
| $17K | ﹤0.01% |
3,510
+2,200
| +168% | +$14.1K |
|
|
SY
2450
So-Young International
SY
$197M
| $17K | ﹤0.01% |
24,100
-10,500
| -30% | -$9.32K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.